ANRS CO3 AQUITAINE - Natural history and sub-treatment of HIV infection

Head :
Dabis François, Équipe INSERM, U897, VIH & ADDICTIONS

Last update : 07/02/2015 | Version : 3 | ID : 3620

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Natural history and sub-treatment of HIV infection
Sign or acronym ANRS CO3 AQUITAINE
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation N° 88-84 (05/07/1988), N° 88-142 (29/11/1988)
General Aspects
Medical area Immunology
Infectious diseases
Keywords HIV infection, epidemiological surveillance, patient care, immunology
Scientific investigator(s) (Contact)
Name of the director Dabis
Surname François
Address 146 rue Léo Saignat 33076 Bordeaux cedex
Phone +33 (0)5 57 57 14 36
Email francois.dabis@isped.u-bordeaux2.fr
Unit Équipe INSERM, U897, VIH & ADDICTIONS
Organization ISPED- Institut de Santé Publique d'Epidémiologie et de
Collaborations
Participation in projects, networks and consortia Yes
Details Implication in a cohort network: EPAVIH, COPANA, AC7(COHORTES ANRS) Inclusion in a European project: CASCADE, DAD, ART-CC, EURO-SIDA, COHERE, HIV-TUBERCULOSIS
Others Other related cohorts: fhdh; nice
Funding
Funding status Mixed
Details ANRS- Agence Nationale de la Recherche sur le Sida et les hépatites virales, SIDACTION
Governance of the database
Sponsor(s) or organisation(s) responsible CHU BORDEAUX
Organisation status Public
Sponsor(s) or organisation(s) responsible UNIVERSITE DE BORDEAUX II
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Longitudinal study (except cohorts)
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Prospective
Database objective
Main objective Main objective: study the natural history and sub-treatment of the infection by the HIV.
Secondary objectives:
- Realize an epidemiological surveillance of the treatment of HIV infection
- Analyze the progression of the infection and study the prognostic factors of this evolution
- Evaluate the arrangements for patients caring
- Study their impact on the disease progression
Inclusion criteria HIV-positive patients, at any clinical stage .Seen at least once in consultation or hospitalization .13 years or older at the time of the inclusion in the study .Freely consent
Population type
Age Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Gender Male
Woman
Geography area Departmental
French regions covered by the database Aquitaine Limousin Poitou-Charentes
Detail of the geography area 13 hospital departments in Aquitaine: Bordeaux, Libourne, Bayonne, Dax, Pau, Périgueux, Villeneuve sur Lot, Mont de Marsan and Arcachon
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 01/1987
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 8677 (31/12/2012)
Data
Database activity Current data collection
Type of data collected Clinical data
Biological data
Clinical data (detail) Medical registration
Details of collected clinical data Clinical examination at inclusion and during the follow-up. Information collected through the clinical examination: - At inclusion, the record includes unique kind of variables: socio-demographic characteristics, risk factors for HIV infection, mode of transmission, date of first positive serology and diagnostic circumstances; eventually, date of the last negative serology, transfusion or risk exposure period. The inclusion record incorporates progressive variables: - Clinical examination data, specific pathologies diagnostics, classification according to the American centers for diseases control (CDC)(MMWR 1986;35:334-9) and the aids classification recognized by WHO/CDC, taken over by the General Health Direction (DGS) in 1987 (bull epidemiol HEBD 1987; (51):201-3) and modified in 1993 (bull epidemiol HEBD 1993 ; (11) : 47-8); - Sexual practices and drug addiction, lifestyle, cardiovascular risk factors; - Hematological, virological, immunological, biochemical and serological check; prescribed therapeutics, treatment history; During each follow-up, the questionnaire will allow to collect again all the information concerning progressive variables.
Biological data (detail) Virological markers, immunological
Presence of a biobank Yes
Contents of biobank Serum
Plasma
DNA
Details of biobank content Serum bank, Plasma bank, DNA bank
Health parameters studied Health event/morbidity
Health event/mortality
Health care consumption and services
Care consumption (detail) Hospitalization
Medical/paramedical consultation
Procedures
Data collection method Clinical examination: manual data entry Biological examination: manual data entry
Quality procedure(s) used Coherence request after computer data entry. Missing data checked back to the original file. Doctors remainders for follow-up visits. Internal and external quality audit reports every 2 years. Validation of deaths. Patients receive information about the use of their data.
Participant monitoring Yes
Details on monitoring of participants Unlimited duration.
Links to administrative sources Yes
Linked administrative sources (detail) CépiDC (Epidemiological center for medical causes of death
Promotion and access
Promotion
Link to the document http://www.hal.inserm.fr/ANRSCO3
Description List of publications in HAL
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/?term=%28ANRS+CO3+Aquitaine+Cohort%29+OR+ANRS-CO3+OR+%28D.A.D+OR+DAD%29+AND+%28Dabis[author]+OR+Worm[author]+OR+sabin[author]+OR+reiss[author]+OR+Friis-Moller[author]+OR+law[author]%29%29+OR+%28cohere+AND+%28hiv+OR+AIDS%29%29+OR+ART-CC+OR+%22cascade+collaboration%22+OR+HIV-causal+collaboration+NOT+23686153[uid]
Description List of publications in Pubmed
Access
Terms of data access (charter for data provision, format of data, availability delay) Data utilization possible for academic teams and for industrials. Access condition in agreement with the steering committee
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05